Sterling Capital Management’s Integra LifeSciences IART Stock Holding History

Sterling Capital Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$24.8K	Sell	1,380 -855	-38%	-$12K	﹤0.01%	1791
2026 Q1	$21.1K	Sell	2,235 -1,650	-42%	-$18.1K	﹤0.01%	2007
2025 Q4	$48.3K	Sell	3,885 -743	-16%	-$9.88K	﹤0.01%	1816
2025 Q3	$66.3K	Buy	4,628 +2,815	+155%	+$38.6K	﹤0.01%	1671
2025 Q2	$22.2K	Buy	1,813 +646	+55%	+$9.38K	﹤0.01%	1755
2025 Q1	$25.7K	Sell	1,167 -999	-46%	-$23.5K	﹤0.01%	1591
2024 Q4	$49.1K	Buy	2,166 +1,931	+822%	+$42.1K	﹤0.01%	1615
2024 Q3	$4.27K	Buy	+235	New	+$5.45K	﹤0.01%	1823

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Sterling Capital Management's IART Position: Q2 2026 in Review

Sterling Capital Management reduced its Integra LifeSciences (IART) stake by 38% in Q2 2026, selling an estimated $12K and leaving 1,380 shares worth $24.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

Sterling Capital Management first reported a position in IART in Q3 2024 and has held it in 8 quarters since. The position peaked at $66.3K in Q3 2025. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Sterling Capital Management held 1,380 shares of Integra LifeSciences worth $24.8K as of Q2 2026.
Sterling Capital Management sold 855 Integra LifeSciences shares in Q2 2026, an estimated $12K.
Integra LifeSciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1791 holding.
Sterling Capital Management first reported a position in Integra LifeSciences in Q3 2024 and has held it in 8 quarters since.
Sterling Capital Management's Integra LifeSciences position peaked at $66.3K in Q3 2025.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.